These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24870777)

  • 1. Preparation of selenium-enriched Bifidobacterium longum and its effect on tumor growth and immune function of tumor-bearing mice.
    Yin Y; Wang RR; Wang Y; Wang JJ; Xu GX
    Asian Pac J Cancer Prev; 2014; 15(8):3681-6. PubMed ID: 24870777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of γ-Glutamyl-Selenomethionine as the Principal Selenium Metabolite in a Selenium-Enriched Probiotic,
    Zhu H; Bierla K; Jin X; Szpunar J; Chen D; Lobinski R
    J Agric Food Chem; 2022 Jun; 70(22):6726-6736. PubMed ID: 35607941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer.
    Fu GF; Li X; Hou YY; Fan YR; Liu WH; Xu GX
    Cancer Gene Ther; 2005 Feb; 12(2):133-40. PubMed ID: 15565182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of selenium enriched-Bifidobacterium longum DD98, and its repairing effects on antibiotic-induced intestinal dysbacteriosis in mice.
    Zhu H; Zhou Y; Qi Y; Ji R; Zhang J; Qian Z; Wu C; Tan J; Shao L; Chen D
    Food Funct; 2019 Aug; 10(8):4975-4984. PubMed ID: 31343650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the fermentation process on the selenite metabolism and selenium incorporation and speciation in a probiotic Bifidobacterium longum.
    Zhu H; Bierla K; Tan J; Szpunar J; Chen D; Lobinski R
    Metallomics; 2023 Jan; 15(1):. PubMed ID: 36583695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of Bifidobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mouse-transplanted tumors.
    Zhu LP; Yin Y; Xing J; Li C; Kou L; Hu B; Wu ZW; Wang JJ; Xu GX
    Cancer Sci; 2009 Oct; 100(10):1986-90. PubMed ID: 19678823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventative effects of selenium-enriched
    Qiu Y; Zhang J; Ji R; Zhou Y; Shao L; Chen D; Tan J
    Benef Microbes; 2019 May; 10(5):569-577. PubMed ID: 30964326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of isotope dilution analysis for the evaluation of extraction conditions in the determination of total selenium and selenomethionine in yeast-based nutritional supplements.
    Hinojosa Reyes L; Marchante-Gayón JM; García Alonso JI; Sanz-Medel A
    J Agric Food Chem; 2006 Mar; 54(5):1557-63. PubMed ID: 16506800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth-inhibition of S180 residual-tumor by combination of cyclophosphamide and chitosan oligosaccharides in vivo.
    Zhai X; Yuan S; Yang X; Zou P; Shao Y; Abd El-Aty AM; Hacımüftüoğlu A; Wang J
    Life Sci; 2018 Jun; 202():21-27. PubMed ID: 29626528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenium-Bifidobacterium longum as a delivery system of endostatin for inhibition of pathogenic bacteria and selective regression of solid tumor.
    Li C; Chen X; Kou L; Hu B; Zhu LP; Fan YR; Wu ZW; Wang JJ; Xu GX
    Exp Ther Med; 2010 Jan; 1(1):129-135. PubMed ID: 23136605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of Bifidobacterium longum-mediated human interleukin-2 with endostatin or TRAIL in transplanted tumors in mice.
    Yin Y; Kou L; Wang JJ; Xu GX
    Exp Ther Med; 2012 Mar; 3(3):481-486. PubMed ID: 22969915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of Selenomethionine-Enriched Bifidobacterium bifidum BGN4 via Sodium Selenite Biocatalysis.
    Jin W; Yoon C; Johnston TV; Ku S; Ji GE
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutral polysaccharide from Panax notoginseng enhanced cyclophosphamide antitumor efficacy in hepatoma H22-bearing mice.
    Liu YH; Qin HY; Zhong YY; Li S; Wang HJ; Wang H; Chen LL; Tang X; Li YL; Qian ZY; Li HY; Zhang L; Chen T
    BMC Cancer; 2021 Jan; 21(1):37. PubMed ID: 33413214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium-enriched Bifidobacterium longum DD98 attenuates irinotecan-induced intestinal and hepatic toxicity in vitro and in vivo.
    Zhu H; Lu C; Gao F; Qian Z; Yin Y; Kan S; Chen D
    Biomed Pharmacother; 2021 Nov; 143():112192. PubMed ID: 34649340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetic effects of selenium-enriched Bifidobacterium longum DD98 in type 2 diabetes model of mice.
    Zhao D; Zhu H; Gao F; Qian Z; Mao W; Yin Y; Tan J; Chen D
    Food Funct; 2020 Jul; 11(7):6528-6541. PubMed ID: 32638790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium-enriched
    Jin X; Hu Y; Lin T; Gao F; Xu Z; Hou X; Yin Y; Kan S; Zhu H; Chen D
    Food Funct; 2023 Jun; 14(11):5355-5374. PubMed ID: 37212199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Ononis hirta and Bifidobacterium longum decreases syngeneic mouse mammary tumor burden and enhances immune response.
    Talib WH; Mahasneh AM
    J Cancer Res Ther; 2012; 8(3):417-23. PubMed ID: 23174725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total selenium and selenomethionine in pharmaceutical yeast tablets: assessment of the state of the art of measurement capabilities through international intercomparison CCQM-P86.
    Goenaga-Infante H; Sturgeon R; Turner J; Hearn R; Sargent M; Maxwell P; Yang L; Barzev A; Pedrero Z; Cámara C; Díaz Huerta V; Fernández Sánchez ML; Sanz-Medel A; Emese K; Fodor P; Wolf W; Goldschmidt R; Vacchina V; Szpunar J; Valiente L; Huertas R; Labarraque G; Davis C; Zeisler R; Turk G; Rizzio E; Mackay LG; Myors RB; Saxby DL; Askew S; Chao W; Jun W
    Anal Bioanal Chem; 2008 Jan; 390(2):629-42. PubMed ID: 17938894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.